Latest updates for Monoclonal Antibodies

Fresh curated links around Monoclonal antibodies are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • AAN226. Ocrelizumab and ADA. Is it too good to be true?
  • Antibodies in CNS inhibited by natalizumab, What does this tell us about antibodies?
  • Mutating Antibodies for Easier Drug-Conjugate Manufacturing

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

multiple-sclerosis-research.org /1 month ago

AAN226. Ocrelizumab and ADA. Is it too good to be true?

Anti-drug antibodies can stop drugs from working and can cause infusion reactions. They are rare to common occurrances due to the target the drug, the person, the assay, the report...

Read source
multiple-sclerosis-research.org /1 month ago

Antibodies in CNS inhibited by natalizumab, What does this tell us about antibodies?

It says to me the antibodies in the CNS are inpart generated by the peripheral immune system entering the CNS as natalizumab blocks cells entering the inflammed CNS Background: Cer...

Read source
genengnews.com /1 week ago

Mutating Antibodies for Easier Drug-Conjugate Manufacturing

Mutations engineered into antibodies could help companies developing the next generation of antibody-drug conjugates by providing convenient general-purpose “lock-on” locations for...

Read source
genengnews.com /1 month ago

Targeted Precision, Complex Promise

Antibody-drug conjugates (ADCs) have evolved from an elegant scientific concept into one of oncology’s most dynamic therapeutic classes. By fusing the targeting specificity of mono...

Read source
multiple-sclerosis-research.org /1 month ago

Natalizumab-Antibodies

This study looks at anti-drug antibodies against natalizumab and suggests that loss of efficacy is one of the better predictors of the response, but suggests that looking for ADA a...

Read source
genengnews.com /3 weeks ago

Human Antibodies Identified That Have Potential To Prevent and Treat Measles Virus

Scientists identified human mAbs from a previously measles-vaccinated human, which in a rodent model of measles infection reduced viral load 500-fold, and which could form the basi...

Read source
genengnews.com /1 month ago

Monoclonal Antibodies: Unlocking Cost and Efficiency Gains in Downstream Processing

In this webinar, our speaker will explore a series of practical, chromatography-focused strategies designed to enhance mAb purification performance while reducing cost of goods (CO...

Read source
bioengineer.org /1 month ago

Vanderbilt Center for Antibody Therapeutics Partners to Develop Novel Anti-Measles Antibody Treatment

In a remarkable advancement that addresses the escalating global challenge of measles outbreaks, the Vanderbilt Center for Antibody Therapeutics has entered into a strategic option...

Read source
neurosciencenews.com /2 weeks ago

Rogue Antibodies Drive Tau Pathology

A new study establishes a direct causal link between IgLON5 antibodies and Tau pathology. By applying patient antibodies to mouse models, the team discovered that antibody-induced...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Monoclonal Antibodies

bioengineer.org

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

multiple-sclerosis-research.org

Recent coverage from public sources
Public source

neurosciencenews.com

Recent coverage from public sources
Public source